A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Status
- RECRUITING
- Phase
- N/A
Apatinib With Pembrolizumab in Previously Treated Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Investigate The Effectiveness Of Atezolizumab In Patients With Inoperable Locally-Advanced Or Metastatic Urothelial Carcinoma Of The Urinary Tract (Announce)
- Status
- TERMINATED
- Phase
- N/A
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Registry Platform Urologic Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina
- Status
- COMPLETED
- Phase
- N/A
Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction
- Status
- UNKNOWN
- Phase
- N/A
Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of ADXS-NEO Expressing Personalized Tumor Antigens
- Status
- TERMINATED
- Phase
- PHASE1
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1